205 related articles for article (PubMed ID: 17416753)
1. S100A6 is increased in a stepwise manner during pancreatic carcinogenesis: clinical value of expression analysis in 98 pancreatic juice samples.
Ohuchida K; Mizumoto K; Yu J; Yamaguchi H; Konomi H; Nagai E; Yamaguchi K; Tsuneyoshi M; Tanaka M
Cancer Epidemiol Biomarkers Prev; 2007 Apr; 16(4):649-54. PubMed ID: 17416753
[TBL] [Abstract][Full Text] [Related]
2. Sonic hedgehog is an early developmental marker of intraductal papillary mucinous neoplasms: clinical implications of mRNA levels in pancreatic juice.
Ohuchida K; Mizumoto K; Fujita H; Yamaguchi H; Konomi H; Nagai E; Yamaguchi K; Tsuneyoshi M; Tanaka M
J Pathol; 2006 Sep; 210(1):42-8. PubMed ID: 16794990
[TBL] [Abstract][Full Text] [Related]
3. S100P is an early developmental marker of pancreatic carcinogenesis.
Ohuchida K; Mizumoto K; Egami T; Yamaguchi H; Fujii K; Konomi H; Nagai E; Yamaguchi K; Tsuneyoshi M; Tanaka M
Clin Cancer Res; 2006 Sep; 12(18):5411-6. PubMed ID: 17000674
[TBL] [Abstract][Full Text] [Related]
4. S100A11, a putative tumor suppressor gene, is overexpressed in pancreatic carcinogenesis.
Ohuchida K; Mizumoto K; Ohhashi S; Yamaguchi H; Konomi H; Nagai E; Yamaguchi K; Tsuneyoshi M; Tanaka M
Clin Cancer Res; 2006 Sep; 12(18):5417-22. PubMed ID: 17000675
[TBL] [Abstract][Full Text] [Related]
5. The role of S100A6 in pancreatic cancer development and its clinical implication as a diagnostic marker and therapeutic target.
Ohuchida K; Mizumoto K; Ishikawa N; Fujii K; Konomi H; Nagai E; Yamaguchi K; Tsuneyoshi M; Tanaka M
Clin Cancer Res; 2005 Nov; 11(21):7785-93. PubMed ID: 16278400
[TBL] [Abstract][Full Text] [Related]
6. Over-expression of S100A2 in pancreatic cancer correlates with progression and poor prognosis.
Ohuchida K; Mizumoto K; Miyasaka Y; Yu J; Cui L; Yamaguchi H; Toma H; Takahata S; Sato N; Nagai E; Yamaguchi K; Tsuneyoshi M; Tanaka M
J Pathol; 2007 Nov; 213(3):275-82. PubMed ID: 17940995
[TBL] [Abstract][Full Text] [Related]
7. High nuclear S100A6 (Calcyclin) is significantly associated with poor survival in pancreatic cancer patients.
Vimalachandran D; Greenhalf W; Thompson C; Lüttges J; Prime W; Campbell F; Dodson A; Watson R; Crnogorac-Jurcevic T; Lemoine N; Neoptolemos J; Costello E
Cancer Res; 2005 Apr; 65(8):3218-25. PubMed ID: 15833853
[TBL] [Abstract][Full Text] [Related]
8. Protein profiling in pancreatic juice for detection of intraductal papillary mucinous neoplasm of the pancreas.
Shirai Y; Sogawa K; Yamaguchi T; Sudo K; Nakagawa A; Sakai Y; Ishihara T; Sunaga M; Nezu M; Tomonaga T; Miyazaki M; Saisho H; Nomura F
Hepatogastroenterology; 2008; 55(86-87):1824-9. PubMed ID: 19102401
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic utility of aberrant methylation of tissue factor pathway inhibitor 2 in pure pancreatic juice for pancreatic carcinoma.
Jiang P; Watanabe H; Okada G; Ohtsubo K; Mouri H; Tsuchiyama T; Yao F; Sawabu N
Cancer Sci; 2006 Nov; 97(11):1267-73. PubMed ID: 16965396
[TBL] [Abstract][Full Text] [Related]
10. Quantitative assessment of telomerase activity and human telomerase reverse transcriptase messenger RNA levels in pancreatic juice samples for the diagnosis of pancreatic cancer.
Ohuchida K; Mizumoto K; Ogura Y; Ishikawa N; Nagai E; Yamaguchi K; Tanaka M
Clin Cancer Res; 2005 Mar; 11(6):2285-92. PubMed ID: 15788678
[TBL] [Abstract][Full Text] [Related]
11. Identification of hepatocarcinoma-intestine-pancreas/pancreatitis-associated protein I as a biomarker for pancreatic ductal adenocarcinoma by protein biochip technology.
Rosty C; Christa L; Kuzdzal S; Baldwin WM; Zahurak ML; Carnot F; Chan DW; Canto M; Lillemoe KD; Cameron JL; Yeo CJ; Hruban RH; Goggins M
Cancer Res; 2002 Mar; 62(6):1868-75. PubMed ID: 11912167
[TBL] [Abstract][Full Text] [Related]
12. Quantitative analysis of human telomerase reverse transcriptase in pancreatic cancer.
Ohuchida K; Mizumoto K; Yamada D; Yamaguchi H; Konomi H; Nagai E; Yamaguchi K; Tsuneyoshi M; Tanaka M
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2066-9. PubMed ID: 16609017
[TBL] [Abstract][Full Text] [Related]
13. Aberrant methylation of secreted apoptosis-related protein 2 (SARP2) in pure pancreatic juice in diagnosis of pancreatic neoplasms.
Watanabe H; Okada G; Ohtsubo K; Yao F; Jiang PH; Mouri H; Wakabayashi T; Sawabu N
Pancreas; 2006 May; 32(4):382-9. PubMed ID: 16670620
[TBL] [Abstract][Full Text] [Related]
14. Twist, a novel oncogene, is upregulated in pancreatic cancer: clinical implication of Twist expression in pancreatic juice.
Ohuchida K; Mizumoto K; Ohhashi S; Yamaguchi H; Konomi H; Nagai E; Yamaguchi K; Tsuneyoshi M; Tanaka M
Int J Cancer; 2007 Apr; 120(8):1634-40. PubMed ID: 17236203
[TBL] [Abstract][Full Text] [Related]
15. Detection of human telomerase reverse transcriptase (hTERT) expression in tissue and pancreatic juice from pancreatic cancer.
Hashimoto Y; Murakami Y; Uemura K; Hayashidani Y; Sudo T; Ohge H; Fukuda E; Sueda T; Hiyama E
Surgery; 2008 Jan; 143(1):113-25. PubMed ID: 18154939
[TBL] [Abstract][Full Text] [Related]
16. A highly sensitive and quantitative telomerase activity assay with pancreatic juice is useful for diagnosis of pancreatic carcinoma without problems due to polymerase chain reaction inhibitors: analysis of 100 samples of pancreatic juice from consecutive patients.
Ohuchida K; Mizumoto K; Ishikawa N; Sato N; Nagai E; Yamaguchi K; Takaishi H; Ide T; Tanaka M
Cancer; 2004 Nov; 101(10):2309-17. PubMed ID: 15476274
[TBL] [Abstract][Full Text] [Related]
17. DNA methylation alterations in the pancreatic juice of patients with suspected pancreatic disease.
Matsubayashi H; Canto M; Sato N; Klein A; Abe T; Yamashita K; Yeo CJ; Kalloo A; Hruban R; Goggins M
Cancer Res; 2006 Jan; 66(2):1208-17. PubMed ID: 16424060
[TBL] [Abstract][Full Text] [Related]
18. Increased cytoplasmic S100A6 expression is associated with pulmonary adenocarcinoma progression.
Ishii A; Suzuki M; Satomi K; Kobayashi H; Sakashita S; Kano J; Pei Y; Minami Y; Ishikawa S; Noguchi M
Pathol Int; 2009 Sep; 59(9):623-30. PubMed ID: 19712129
[TBL] [Abstract][Full Text] [Related]
19. Upregulated expression of S100A6 in human gastric cancer.
Yang YQ; Zhang LJ; Dong H; Jiang CL; Zhu ZG; Wu JX; Wu YL; Han JS; Xiao HS; Gao HJ; Zhang QH
J Dig Dis; 2007 Nov; 8(4):186-93. PubMed ID: 17970874
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of growth factors and the urokinase-type plasminogen activator system in pancreatic ductal adenocarcinoma.
Xue A; Scarlett CJ; Jackson CJ; Allen BJ; Smith RC
Pancreas; 2008 Mar; 36(2):160-7. PubMed ID: 18376307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
